Brief: AVITA Medical Submits FDA PMA Supplement To Further Expand Indication To Soft Tissue Repair

AVITA Medical

12/12/2022 15:41

Dec 12 (Reuters) - AVITA Medical Inc  RCEL.O :
    * AVITA MEDICAL SUBMITS FDA PMA SUPPLEMENT TO FURTHER EXPAND
INDICATION TO SOFT TISSUE REPAIR
    * AVITA MEDICAL INC - SUPPLEMENT, IF APPROVED, WILL EXPAND
INDICATION OF RECELL TO INCLUDE SOFT TISSUE REPAIR
    * AVITA MEDICAL INC -  ONCE APPROVED, NEW INDICATION IS
EXPECTED
TO CREATE A SIGNIFICANT GROWTH OPPORTUNITY FOR US BEGINNING JULY
2023
    * AVITA MEDICAL INC - PMA SUPPLEMENT INCLUDES RECENTLY
RELEASED
RESULTS OF PIVOTAL TRIAL FOR SOFT TISSUE REPAIR

Source text for Eikon:  ID:nGNX10q03Y 
Further company coverage:  RCEL.O 
 ((Reuters.Briefs@thomsonreuters.com;))